Diagnomics Inc. is a newly established biotech company at the heart of the Biotech Beach in San Diego California. The company business focuses on products and service development for personalized medicine based on personal genome and advanced bioinformatic analysis. We aim to provide the highest possible quality genome sequencing service and annotation solution from next generation sequencing (NGS) technology to guide personalized medicine based on an individual’s genetic difference. Diagnomics provides full personal genome sequencing and interpretation solutions to biomedical researchers, physicians and individuals seeking to understand the genetic influence of personal health and disease. Led by internationally recognized genome and bioinformatic scientists and engineers, Diagnomics’ team successfully sequenced and analyzed many normal and diseased human genomes including individuals with various cancers and rare genetic diseases. Our vision is developing complete solutions for personal genome sequencing and analysis pipelines which will enable the sequencing of individual genomes as part of routine medical care. Our technology will provide individualized strategies for diagnosing, treating and preventing disease based on information obtained from personal genomes.
There is no investment information
No recent news or press coverage available for Diagnomics.
We care about your data, and we'd love to use cookies make your experience better.
